Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk

Molecular Carcinogenesis

Volumn 49, Issue 1, 2010, Pages 75-84

  Liu, Bing ^a   Zhang, Yongjing ^a   Jin, Mingjuan ^a   Ni, Qin ^a   Liang, Xia ^a   Ma, Xinyuan ^b   Yao, Kaiyan ^b   Li, Qilong ^b   Chen, Kun ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Institute of Cancer Research and Prevention of Jiashan County   (China)

Author keywords

Apoptosis; Cell cycle; Single nucleotide polymorphism; Susceptibility to cancer

Indexed keywords

CASPASE 8; PROTEIN P21;

ACCURACY; ADULT; ARTICLE; CANCER RISK; CODON; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; CASPASE 8; COLORECTAL NEOPLASMS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE DELETION;

EID: 74249093205     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20579     Document Type: Article

References (37)

1. Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: Implications for screening. Lancet Oncol 2005;6:871-876.
2. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005;14:243-250.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
4. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004;4:769-780.
5. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-348.
6. Wikman H, Kettunen E. Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer. Expert Rev Anticancer Ther 2006;6:515-530.
7. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003;22:8543-8567.
8. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002;1:639-649.
9. Rajaraman P, Wang SS, Rothman N, et al. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 2007; 16:1655-1661.
10. Wang W, Spitz MR, Yang H, Lu C, Stewart DJ, Wu X. Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. Clin Cancer Res 2007;13:5974-5981.
11. Ye Y, Yang H, Grossman HB, Dinney C, Wu X, Gu J. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer 2008;112:2467-2474.
12. Fan C, Jin M, Chen K, Zhang Y, Zhang S, Liu B. Case-only study of interactions between metabolic enzymes and smoking in colorectal cancer. BMC Cancer 2007;7:115-122.
13. Zhang Y, Liu B, Jin M, et al. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: A population-based case-control study in China. Cancer Lett 2008;275:102-108.
14. Nasiri H, Forouzandeh M, Rasaee MJ, Rahbarizadeh F. Modified salting-out method: High-yield, high-quality genomic DNA extraction from whole blood using laundry detergent. J Clin Lab Anal 2005;19:229-232.
15. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
16. Wang M, Zhang Z, Tian Y, Shao J, Zhang Z. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer. Clin Cancer Res 2009;15:2567-2572.
17. Gangwar R, Mandhani A, Mittal RD. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population. Ann Surg Oncol 2009;16:2028-2034.
18. Yang M, Sun T, Wang L, et al. Functional variants in cell death pathway genes and risk of pancreatic cancer. Clin Cancer Res 2008;14:3230-3236.
19. Pittman AM, Broderick P, Sullivan K, et al. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. Br J Cancer 2008;98:1434-1436.
20. Li C, Zhao H, Hu Z, et al. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum Mutat 2008;29:1443-1451.
21. Haiman CA, Garcia RR, Kolonel LN, Henderson BE, Wu AH, Le Marchand L. A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nat Genet 2008; 40:259-260, author reply 260-251.
22. Frank B, Rigas SH, Bermejo JL, et al. The CASP 8-652 6N del promoter polymorphism and breast cancer risk: A multicenter study. Breast Cancer Res Treat 2008;111:139-144.
23. Cybulski C, Wokolorczyk D, Gliniewicz B, et al. A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population. Breast Cancer Res Treat 2008;112:367-368.
24. Sun T, Gao Y, Tan W, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 2007;39:605-613.
25. Son JW, Kang HK, Chae MH, et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet 2006;169:121-127.
26. Ritchie MD, Hahn LW, Roodi N, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69:138-147.
27. Chao A, Thun MJ, Connell CJ, et al. Meat consumption and risk of colorectal cancer. J Am Med Assoc 2005;293:172-182.
28. Williams CD, Satia JA, Adair LS, et al. Dietary patterns, food groups, and rectal cancer risk in whites and African-Americans. Cancer Epidemiol Biomarkers Prev 2009;18: 1552-1561.
29. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: Polymorphism, aberrant splicing and cancer risk. Oncogene 2006;25:1620-1628.
30. Pabalan N, Bapat B, Sung L, Jarjanazi H, Francisco-Pabalan O, Ozcelik H. Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:2773-2781.
31. Tan XL, Nieters A, Kropp S, Hoffmeister M, Brenner H, Chang-Claude J. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis. Int J Cancer 2008;122:2573-2580.
32. Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. Oncogene 2006;25:1602-1611.
33. Kibel AS, Suarez BK, Belani J, et al. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma. Cancer Res 2003;63:2033-2036.
34. Li G, Liu Z, Sturgis EM, et al. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2005;26:1596-1602.
35. Ma H, Jin G, Hu Z, et al. Variant genotypes of CDKN1A and CDKN1B are associatedwith an increased risk of breast cancer in Chinese women. Int J Cancer 2006;119:2173-2178.
36. Choi YY, Kang HK, Choi JE, et al. Comprehensive assessment of P21 polymorphisms and lung cancer risk. J Hum Genet 2008;53:87-95.
37. Mousses S, Ozcelik H, Lee PD, Malkin D, Bull SB, Andrulis IL. Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer. Hum Mol Genet 1995;4: 1089-1092.